Perspectives on developing small molecule inhibitors targeting HIV-1 integrase.

J J Tan1, C Liu, X H Sun

  • 1College of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, China.

Summary

Researchers reviewed novel anti-HIV integrase (IN) inhibitors developed using rational drug design over the past five years. These advancements target a crucial enzyme in the HIV-1 life cycle, accelerating the development of new anti-AIDS therapies.